Thermo Fisher Scientific Inc., a leading name in the life sciences and laboratory equipment industry, is headquartered in the United States. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific, the company has established itself as a global powerhouse, with significant operations across North America, Europe, and Asia. Specialising in analytical instruments, reagents, and consumables, Thermo Fisher provides innovative solutions that enhance scientific research and healthcare. Their core offerings include mass spectrometry, chromatography, and molecular biology products, distinguished by their precision and reliability. With a strong market position, Thermo Fisher Scientific is recognised for its commitment to advancing scientific discovery and improving patient outcomes, making it a trusted partner for researchers and healthcare professionals worldwide.
How does Thermo Fisher Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Thermo Fisher Scientific's score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Thermo Fisher Scientific reported total carbon emissions of approximately 282,602,000 kg CO2e, with emissions distributed across all three scopes: 26,379,000 kg CO2e (Scope 1), 748,000 kg CO2e (Scope 2), and a significant 255,474,000 kg CO2e (Scope 3). This data reflects their ongoing commitment to sustainability and climate action. The company has set ambitious targets to reduce its carbon footprint, aiming for a 50% reduction in Scope 1 and 2 emissions by 2030 from a 2018 baseline. Additionally, Thermo Fisher has committed to achieving net-zero emissions across all scopes by 2050. This commitment includes a 90% reduction in Scope 1 and 2 emissions by 2050, and a similar target for Scope 3 emissions, which will be measured from a 2021 baseline. Thermo Fisher's climate strategy aligns with the Science Based Targets initiative (SBTi), ensuring that their targets are consistent with the global goal of limiting temperature rise to 1.5°C. The company has also made strides in renewable energy, with 150 sites powered by renewable sources and a goal to have 90% of its suppliers adopt science-based targets by 2027. Overall, Thermo Fisher Scientific is actively working towards significant emissions reductions and sustainability initiatives, demonstrating leadership in the pharmaceutical and biotechnology sectors.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Thermo Fisher Scientific is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
